BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17322294)

  • 21. Recognition of diverse proteins by members of the immunoglobulin superfamily: delineation of the receptor binding site in the human CD6 ligand ALCAM.
    Skonier JE; Bowen MA; Emswiler J; Aruffo A; Bajorath J
    Biochemistry; 1996 Sep; 35(38):12287-91. PubMed ID: 8823162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sequence conserved between CD5 and CD6 binds an FERM domain and exerts a restraint on T-cell activation.
    Breuning J; Brown MH
    Immunology; 2019 Mar; 156(3):270-276. PubMed ID: 30460991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.
    Castro MA; Oliveira MI; Nunes RJ; Fabre S; Barbosa R; Peixoto A; Brown MH; Parnes JR; Bismuth G; Moreira A; Rocha B; Carmo AM
    J Immunol; 2007 Apr; 178(7):4351-61. PubMed ID: 17371992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the cysteine-rich domain of scavenger receptor MARCO reveals the presence of a basic and an acidic cluster that both contribute to ligand recognition.
    Ojala JR; Pikkarainen T; Tuuttila A; Sandalova T; Tryggvason K
    J Biol Chem; 2007 Jun; 282(22):16654-66. PubMed ID: 17405873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular and functional characterization of mouse S5D-SRCRB: a new group B member of the scavenger receptor cysteine-rich superfamily.
    Miró-Julià C; Roselló S; Martínez VG; Fink DR; Escoda-Ferran C; Padilla O; Vázquez-Echeverría C; Espinal-Marin P; Pujades C; García-Pardo A; Vila J; Serra-Pagès C; Holmskov U; Yélamos J; Lozano F
    J Immunol; 2011 Feb; 186(4):2344-54. PubMed ID: 21217009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domain-specific CD6 monoclonal antibodies identify CD6 isoforms generated by alternative-splicing.
    Santos RF; Oliveira L; Brown MH; Carmo AM
    Immunology; 2019 Aug; 157(4):296-303. PubMed ID: 31162836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationale for treating primary Sjögren's syndrome patients with an anti-CD6 monoclonal antibody (Itolizumab).
    Le Dantec C; Alonso R; Fali T; Montero E; Devauchelle V; Saraux A; Pers JO; Renaudineau Y
    Immunol Res; 2013 Jul; 56(2-3):341-7. PubMed ID: 23576060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
    Chalmers SA; Ayilam Ramachandran R; Garcia SJ; Der E; Herlitz L; Ampudia J; Chu D; Jordan N; Zhang T; Parodis I; Gunnarsson I; Ding H; Shen N; Petri M; Mok CC; Saxena R; Polu KR; Connelly S; Ng CT; Mohan C; Putterman C
    J Clin Invest; 2022 Jan; 132(1):. PubMed ID: 34981775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three-dimensional solution structure and conformational plasticity of the N-terminal scavenger receptor cysteine-rich domain of human CD5.
    Garza-Garcia A; Esposito D; Rieping W; Harris R; Briggs C; Brown MH; Driscoll PC
    J Mol Biol; 2008 Apr; 378(1):129-44. PubMed ID: 18339402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frontline: Optimal T cell activation requires the engagement of CD6 and CD166.
    Hassan NJ; Barclay AN; Brown MH
    Eur J Immunol; 2004 Apr; 34(4):930-40. PubMed ID: 15048703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
    Casadó-Llombart S; Ajami T; Consuegra-Fernández M; Carreras E; Aranda F; Armiger N; Alcaraz A; Mengual L; Lozano F
    Prostate; 2022 Oct; 82(14):1331-1337. PubMed ID: 35767366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of mouse CD6 with novel monoclonal antibodies which enhance the allogeneic mixed leukocyte reaction.
    Starling GC; Whitney GS; Siadak AW; Llewellyn MB; Bowen MA; Farr AG; Aruffo AA
    Eur J Immunol; 1996 Apr; 26(4):738-46. PubMed ID: 8625962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cDNA clone from the sea lamprey Petromyzon marinus coding for a scavenger receptor Cys-rich (SRCR) domain protein.
    Mayer WE; Tichy H
    Gene; 1995 Oct; 164(2):267-71. PubMed ID: 7590341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The conserved scavenger receptor cysteine-rich superfamily in therapy and diagnosis.
    Martínez VG; Moestrup SK; Holmskov U; Mollenhauer J; Lozano F
    Pharmacol Rev; 2011 Dec; 63(4):967-1000. PubMed ID: 21880988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ectodomains of the lymphocyte scavenger receptors CD5 and CD6 interact with tegumental antigens from Echinococcus granulosus sensu lato and protect mice against secondary cystic echinococcosis.
    Mourglia-Ettlin G; Miles S; Velasco-De-Andrés M; Armiger-Borràs N; Cucher M; Dematteis S; Lozano F
    PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006891. PubMed ID: 30500820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD6 regulates T-cell responses through activation-dependent recruitment of the positive regulator SLP-76.
    Hassan NJ; Simmonds SJ; Clarkson NG; Hanrahan S; Puklavec MJ; Bomb M; Barclay AN; Brown MH
    Mol Cell Biol; 2006 Sep; 26(17):6727-38. PubMed ID: 16914752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conserved Bacterial-Binding Peptides of the Scavenger-Like Human Lymphocyte Receptor CD6 Protect From Mouse Experimental Sepsis.
    Martínez-Florensa M; Català C; Velasco-de Andrés M; Cañadas O; Fraile-Ágreda V; Casadó-Llombart S; Armiger-Borràs N; Consuegra-Fernández M; Casals C; Lozano F
    Front Immunol; 2018; 9():627. PubMed ID: 29706953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel member of an ancient superfamily: sponge (Geodia cydonium, Porifera) putative protein that features scavenger receptor cysteine-rich repeats.
    Pancer Z; Munkner J; Muller I; Muller WE
    Gene; 1997 Jul; 193(2):211-8. PubMed ID: 9256079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Ly-1.1 and Ly-1.2 epitopes of murine CD5 map to the membrane distal scavenger receptor cysteine-rich domain.
    Starling GC; Llewellyn MB; Whitney GS; Aruffo A
    Tissue Antigens; 1997 Jan; 49(1):1-6. PubMed ID: 9027958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of mouse ALCAM (CD166): the CD6-binding domain is conserved in different homologs and mediates cross-species binding.
    Bowen MA; Bajorath J; D'Egidio M; Whitney GS; Palmer D; Kobarg J; Starling GC; Siadak AW; Aruffo A
    Eur J Immunol; 1997 Jun; 27(6):1469-78. PubMed ID: 9209500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.